FindTrial
Sign In

This study will check if a blood test called procalcitonin can show how severe pneumonia is when patients are admitted. By measuring this level, we hope doctors can detect serious infection early, give timely treatment, and improve patient recovery.

A study to assess the correlation between procalcitonin values with severity of bacterial community-acquired pneumonia patients admitted in tertiary care hospital,Udupi - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/10/096697
Enrollment
100
Registered
2025-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J13- Pneumonia due to Streptococcus pneumoniae

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Sayanti Pattanayak
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria adult patients are above 18 years has developed symptoms within 48 hours of admission and has no history of hospitalization in last 14 days elevated procalcitonine level more than 0.5

Exclusion criteria

Exclusion criteria: Exclusion Criteria patient age more than 18 years patients who has history of hospitalization within 14 days patient with hospital acquired pneumonia

Design outcomes

Primary

MeasureTime frame
primary outcomes -correlation between procalcitonin and CURB-65/PSI -Correlation between procalcitonin and inflammatory markersTimepoint: 48 hours—

Secondary

MeasureTime frame
Mortality, ventilator free daysTimepoint: 1 week—

Countries

India

Contacts

Public ContactJanet Alva

Manipal College Of Nursing, Manipal

janet.a@manipal.edu9845646725

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026